Mini Review
Published on 13 Feb 2026
From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment
in Molecular and Cellular Pathology
- 105 views
Mini Review
Published on 13 Feb 2026
in Molecular and Cellular Pathology
Review
Published on 13 Feb 2026
in Molecular and Cellular Pathology
Original Research
Published on 13 Feb 2026
in Molecular and Cellular Pathology
Editorial
Published on 13 Feb 2026
in Molecular and Cellular Pathology
Review
Published on 12 Feb 2026
in Molecular and Cellular Pathology
Opinion
Published on 12 Feb 2026
in Molecular and Cellular Pathology
Editorial
Published on 12 Feb 2026
in Molecular and Cellular Pathology
Perspective
Accepted on 11 Feb 2026
in Molecular and Cellular Pathology
Correction
Published on 10 Feb 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 09 Feb 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 09 Feb 2026
in Molecular and Cellular Pathology
Mini Review
Accepted on 09 Feb 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 09 Feb 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 09 Feb 2026
in Molecular and Cellular Pathology
Correction
Accepted on 06 Feb 2026
in Molecular and Cellular Pathology
Mini Review
Published on 06 Feb 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 04 Feb 2026
in Molecular and Cellular Pathology
Review
Accepted on 03 Feb 2026
in Molecular and Cellular Pathology
Review
Published on 02 Feb 2026
in Molecular and Cellular Pathology
Review
Published on 30 Jan 2026
in Molecular and Cellular Pathology
Original Research
Published on 30 Jan 2026
in Molecular and Cellular Pathology
Original Research
Published on 30 Jan 2026
in Molecular and Cellular Pathology
Review
Published on 30 Jan 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 29 Jan 2026
in Molecular and Cellular Pathology